BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 17200910)

  • 1. Gastric emptying of glucose solution and associated plasma concentrations of GLP-1, GIP, and PYY before and after fundoplication.
    Miholic J; Hoffmann M; Holst JJ; Lenglinger J; Mittlböck M; Bergmann H; Stacher G
    Surg Endosc; 2007 Feb; 21(2):309-14. PubMed ID: 17200910
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of gastric emptying by acarbose is correlated with GLP-1 response and accompanied by CCK release.
    Enç FY; Imeryüz N; Akin L; Turoğlu T; Dede F; Haklar G; Tekeşin N; Bekiroğlu N; Yeğen BC; Rehfeld JF; Holst JJ; Ulusoy NB
    Am J Physiol Gastrointest Liver Physiol; 2001 Sep; 281(3):G752-63. PubMed ID: 11518688
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Circulating concentrations of glucagon-like peptide 1, glucose-dependent insulinotropic peptide, peptide YY, and insulin in client-owned lean, overweight, and diabetic cats.
    McMillan CJ; Zapata RC; Chelikani PK; Snead EC; Cosford K
    Domest Anim Endocrinol; 2016 Jan; 54():85-94. PubMed ID: 26609567
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gastric emptying and release of incretin hormones after glucose ingestion in humans.
    Schirra J; Katschinski M; Weidmann C; Schäfer T; Wank U; Arnold R; Göke B
    J Clin Invest; 1996 Jan; 97(1):92-103. PubMed ID: 8550855
    [TBL] [Abstract][Full Text] [Related]  

  • 5. GLP-1 slows solid gastric emptying and inhibits insulin, glucagon, and PYY release in humans.
    Näslund E; Bogefors J; Skogar S; Grybäck P; Jacobsson H; Holst JJ; Hellström PM
    Am J Physiol; 1999 Sep; 277(3):R910-6. PubMed ID: 10484511
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanism of action of pre-meal consumption of whey protein on glycemic control in young adults.
    Akhavan T; Luhovyy BL; Panahi S; Kubant R; Brown PH; Anderson GH
    J Nutr Biochem; 2014 Jan; 25(1):36-43. PubMed ID: 24314863
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The 2-monoacylglycerol moiety of dietary fat appears to be responsible for the fat-induced release of GLP-1 in humans.
    Mandøe MJ; Hansen KB; Hartmann B; Rehfeld JF; Holst JJ; Hansen HS
    Am J Clin Nutr; 2015 Sep; 102(3):548-55. PubMed ID: 26178726
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exaggerated secretion of glucagon-like peptide-1 (GLP-1) could cause reactive hypoglycaemia.
    Toft-Nielsen M; Madsbad S; Holst JJ
    Diabetologia; 1998 Oct; 41(10):1180-6. PubMed ID: 9794105
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hyperglycemia acutely lowers the postprandial excursions of glucagon-like Peptide-1 and gastric inhibitory polypeptide in humans.
    Vollmer K; Gardiwal H; Menge BA; Goetze O; Deacon CF; Schmidt WE; Holst JJ; Meier JJ
    J Clin Endocrinol Metab; 2009 Apr; 94(4):1379-85. PubMed ID: 19174495
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gastric emptying, gastric secretion and enterogastrone response after administration of milk proteins or their peptide hydrolysates in humans.
    Calbet JA; Holst JJ
    Eur J Nutr; 2004 Jun; 43(3):127-39. PubMed ID: 15168035
    [TBL] [Abstract][Full Text] [Related]  

  • 11. alpha-Glucosidase inhibition (acarbose) fails to enhance secretion of glucagon-like peptide 1 (7-36 amide) and to delay gastric emptying in Type 2 diabetic patients.
    Hücking K; Kostic Z; Pox C; Ritzel R; Holst JJ; Schmiegel W; Nauck MA
    Diabet Med; 2005 Apr; 22(4):470-6. PubMed ID: 15787675
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Associations between Postprandial Gut Hormones and Markers of Bone Remodeling.
    Jensen NW; Clemmensen KKB; Jensen MM; Pedersen H; Færch K; Diaz LJ; Quist JS; Størling J
    Nutrients; 2021 Sep; 13(9):. PubMed ID: 34579074
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of age on concentrations of plasma cholecystokinin, glucagon-like peptide 1, and peptide YY and their relation to appetite and pyloric motility.
    MacIntosh CG; Andrews JM; Jones KL; Wishart JM; Morris HA; Jansen JB; Morley JE; Horowitz M; Chapman IM
    Am J Clin Nutr; 1999 May; 69(5):999-1006. PubMed ID: 10232642
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expected values for gastrointestinal and pancreatic hormone concentrations in healthy volunteers in the fasting and postprandial state.
    Meek CL; Lewis HB; Burling K; Reimann F; Gribble F
    Ann Clin Biochem; 2021 Mar; 58(2):108-116. PubMed ID: 33175577
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fasting and post prandial pancreatic and enteroendocrine hormone levels in obese and non-obese participants.
    Bannon CA; Meek CL; Reimann F; Gribble FM
    Peptides; 2024 Jun; 176():171186. PubMed ID: 38490484
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gastric emptying, incretin hormone secretion, and postprandial glycemia in cystic fibrosis--effects of pancreatic enzyme supplementation.
    Kuo P; Stevens JE; Russo A; Maddox A; Wishart JM; Jones KL; Greville H; Hetzel D; Chapman I; Horowitz M; Rayner CK
    J Clin Endocrinol Metab; 2011 May; 96(5):E851-5. PubMed ID: 21389144
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gastric sensorimotor functions and hormone profile in normal weight, overweight, and obese people.
    Vazquez Roque MI; Camilleri M; Stephens DA; Jensen MD; Burton DD; Baxter KL; Zinsmeister AR
    Gastroenterology; 2006 Dec; 131(6):1717-24. PubMed ID: 17087952
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gastric emptying, glucose metabolism and gut hormones: evaluation of a common preoperative carbohydrate beverage.
    Vermeulen MA; Richir MC; Garretsen MK; van Schie A; Ghatei MA; Holst JJ; Heijboer AC; Uitdehaag BM; Diamant M; Eekhoff EM; van Leeuwen PA; Ligthart-Melis GC
    Nutrition; 2011 Sep; 27(9):897-903. PubMed ID: 21255977
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intravenous ghrelin accelerates postoperative gastric emptying and time to first bowel movement in humans.
    Falkén Y; Webb DL; Abraham-Nordling M; Kressner U; Hellström PM; Näslund E
    Neurogastroenterol Motil; 2013 Jun; 25(6):474-80. PubMed ID: 23527561
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lower plasma levels of glucose-dependent insulinotropic peptide (GIP) and pancreatic polypeptide (PP) in patients with ductal adenocarcinoma of the pancreas and their relation to the presence of impaired glucoregulation and weight loss.
    Škrha J; Bušek P; Uhrová J; Hrabal P; Kmochová K; Laclav M; Bunganič B; Frič P
    Pancreatology; 2017; 17(1):89-94. PubMed ID: 28027898
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.